BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29691938)

  • 1. HLA-DRB1*15:03 and HLA-DRB1*11: useful predictive alleles for alloantibody production in thalassemia patients.
    Darvishi P; Sharifi Z; Azarkeivan A; Akbari A; Pourfathollah AA
    Transfus Med; 2019 Jun; 29(3):179-184. PubMed ID: 29691938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between HLA-DRB1*01 and HLA-DRB1*15 with alloimmunisation in transfusion-dependent patients with thalassaemia.
    Ebrahimi M; Dayer D; Jalalifar MA; Keikhaei B; Tahan Nejad Asadi Z
    Transfus Med; 2020 Aug; 30(4):275-280. PubMed ID: 32227529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-DRB1*11 group-specific allele is a predictor for alloantibody production in the transfusion-dependent thalassemia patients.
    Ebrahimi M; Maleknia M; Parav N; Mohammadi MB; Mortazavi Y; Saki N; Rahim F
    Transfus Apher Sci; 2020 Jun; 59(3):102729. PubMed ID: 31941582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value Evaluation of HLA-DRB1*07:01, *10, *12, *13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia.
    Mezginejad F; Anani Sarab GR; Atarodi K; Oodi A; Azarkeivan A
    Transfus Apher Sci; 2021 Dec; 60(6):103271. PubMed ID: 34535395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
    Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
    Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
    Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
    J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
    Guelsin GA; Rodrigues C; Visentainer JE; De Melo Campos P; Traina F; Gilli SC; Saad ST; Castilho L
    Blood Transfus; 2015 Jan; 13(1):53-8. PubMed ID: 24960644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*01:01, but not HLA-DRB1:1503 or HLA-DRB1*11, is associated with decreased inhibitor risk in Iranian hemophilia A patients.
    Hosseini S; Arabi S; Yari F; Pourfatollah A; Rezaie N; Moazezi S; Aghaie A
    Transfus Apher Sci; 2019 Oct; 58(5):669-673. PubMed ID: 31537466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.
    Schonewille H; Doxiadis II; Levering WH; Roelen DL; Claas FH; Brand A
    Transfusion; 2014 Aug; 54(8):1971-80. PubMed ID: 24654685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 alleles of susceptibility and protection in Iranians with autoimmune hepatitis.
    Baharlou R; Faghihi-Kashani A; Faraji F; Najafi-Samei M; Setareh M; Zamani F; Tajik N
    Hum Immunol; 2016 Apr; 77(4):330-5. PubMed ID: 26780502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*09:01 allele is associated with anti-E immunization in a Chinese population.
    Tian L; Hou L; Wang L; Xu H; Xiao J; Ying B
    Transfusion; 2018 Jun; 58(6):1536-1539. PubMed ID: 29516495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex (MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR).
    Dadashi M; Ostadali M; Mohammadi S; Azarkeivan A; Zadsar M
    Transfus Clin Biol; 2023 May; 30(2):205-211. PubMed ID: 36328308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech population.
    Maluskova A; Mrazek F; Pauliskova M; Kovarova P; Koristka M; Jindra P; Cermakova Z
    Vox Sang; 2017 Feb; 112(2):156-162. PubMed ID: 28052334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population.
    Picard C; Frassati C; Basire A; Buhler S; Galicher V; Ferrera V; Reviron D; Zappitelli JP; Bailly P; Chiaroni J
    Transfusion; 2009 Nov; 49(11):2412-7. PubMed ID: 19702653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DRB1 alleles with anti-D alloimmunization in RhD negative pregnant women in India.
    Jain A; Sharma RR; Minz RW; Saha SC
    Transfus Apher Sci; 2023 Dec; 62(6):103789. PubMed ID: 37673757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of HLA-DRB1 and HLA-DQB1 alleles in Lak population of Iran.
    Varzi AM; Shahsavar F; Tarrahi MJ
    Hum Immunol; 2016 Jul; 77(7):580-3. PubMed ID: 27189628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
    Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
    Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.